Advancing Skin Health: Experts Call for Consensus Human Skin Cell Atlas

TL;DR Summary
In August 2023, experts at the Asembia Specialty Pharmacy Summit emphasized the importance of listening to patients and caregivers when treating pediatric atopic dermatitis (AD), a skin condition characterized by inflamed and itchy rashes. Sleep disturbances and anxiety are common among caregivers, highlighting the need for comprehensive care. Meanwhile, a study found that upadacitinib maintained its efficacy for 3 years in patients with psoriatic arthritis, with no new safety concerns identified. Additionally, lebrikizumab showed promising results in improving or clearing the skin of adult and adolescent patients with moderate to severe AD.
Topics:science#health#lebrikizumab#pediatric-atopic-dermatitis#psoriatic-arthritis#skin-health#upadacitinib
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
86%
657 → 92 words
Want the full story? Read the original article
Read on Pharmacy Times